a monocentric,non interventional, prospective study to compare cardiovascular risk in patients with Obstructive Sleep Apnea/Hypopnea Syndrome treated with Continuous Positive Airway Pressure (CPAP) and Mandibular Advancement Orthosis.
The first-line treatment of severe Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) is nocturnal ventilation with Continuous Positive Airway Pressure (CPAP). and The second-line treatment is the mandibular advancement orthosis (MAO)\]. CPAP is the most effective treatment to reduce the apnea-hypopnea index (AHI). However, its tolerance is sometimes difficult, causing many discontinuations. The purpose of this review is to evaluate a vascular morbimortality criteria: * Cardiovascular: myocardial infarction, heart failure, rhythm disorder * Neurological: transient or non transient stroke * ophthalmologic: anterior ischemic optic neuropathy, occlusion of the central artery or central retinal vein occlusion
Study Type
OBSERVATIONAL
Enrollment
172
Ch Valence
Valence, Drome, France
morbimortality vascular criteria
Presence or absence of cardiovascular event
Time frame: up to 6 months
morbimortality vascular criteria
Presence or absence of neurologic event
Time frame: up to 6 months
morbimortality vascular criteria
Presence or absence of ophthalmologic event
Time frame: up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.